Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

June 26, 2024

Study Completion Date

August 28, 2025

Conditions
Muscle AtrophyMuscle WeaknessBlood Flow
Interventions
DEVICE

Intervention Group

Subjects will receive a functional neuromodulation device to wear for 1 hour daily up to four weeks or until hospital discharge, whichever came first.

DEVICE

Control Group

Subjects will receive a non-functional neuromodulation device to wear for 1 hour daily up to four weeks or until hospital discharge, whichever came first.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Avazzia, Inc

INDUSTRY

lead

Bijan Najafi, PhD

OTHER

NCT06238609 - Neuromodulation for Prevention of Intensive Care Unit Acquired Weakness and Post Intensive Care Syndrome | Biotech Hunter | Biotech Hunter